By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mayo Clinic has launched a project that will use genome and tumor sequencing and mouse models to help develop and tailor breast cancer treatment and to discover why some tumors do not respond to therapy, Mayo said today.

Researchers in the Breast Cancer Genome Guided Therapy Study, or the Beauty Project, will sequence the genomes of breast cancer patients before they are treated and the genomes from their cancer tumors both before and after treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.